Table 4 Lower limits of quantification.

From: Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study

 

LLOQ (pg/ml)

DHA

0.02

DPA

0.15

EPA

0.01

18-HEPE

0.24

17-HDHA

0.33

14-HDHA

0.08

RvE1

0.21

RvD1

0.64

RvD2

0.97

RvD3

0.30

RvD4

0.42

RvD5

0.25

MaR1

0.74

MaR2

0.18

PD1

0.15

PDX

0.30

LXA4

0.28

LXB4

0.25

PGE2

0.30

PGD2

0.17

PGF2α

0.43

TXB2

0.29

LTB4

0.25

  1. The LLOQ was defined as the analyte concentration with a signal/noise ≥ fivefold the signal/noise of the blank solution. Abbreviations: docosahexaenoic acid (DHA), docosapentaenoic acid (DPA), eicosapentaenoic acid (EPA), hydroxyeicosapentaenoic acid (HEPE), hydroxy docosahexaenoic acid (HDHA), resolvin (Rv), maresin (MaR), protectin (PD), lipoxin (LX), prostaglandin (PG), tromboxane (TX), and leukotriene (LT).
Back to article page